121 related articles for article (PubMed ID: 23221606)
21. Endometrial stromal sarcomas: immunoprofile with emphasis on HMB45 reactivity.
Albores-Saavedra J; Dorantes-Heredia R; Chablé-Montero F; Chanona-Vilchis J; Pérez-Montiel D; Lino-Silva LS; González-Romo MA; Ramírez-Jaramillo JM; Henson DE
Am J Clin Pathol; 2014 Jun; 141(6):850-5. PubMed ID: 24838330
[TBL] [Abstract][Full Text] [Related]
22. Androgen Receptor Expression in Endometrial Stromal Sarcoma: Correlation With Clinicopathologic Features.
Roy M; Kumar S; Bhatla N; Ray MD; Kumar L; Jain D; Phulware R; Mathur SR
Int J Gynecol Pathol; 2017 Sep; 36(5):420-427. PubMed ID: 28114189
[TBL] [Abstract][Full Text] [Related]
23. Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER-1): potential basis for a new therapeutic approach.
Moinfar F; Gogg-Kamerer M; Sommersacher A; Regitnig P; Man YG; Zatloukal K; Denk H; Tavassoli FA
Am J Surg Pathol; 2005 Apr; 29(4):485-9. PubMed ID: 15767802
[TBL] [Abstract][Full Text] [Related]
24. Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma.
Yoon JY; de Kock L; Stewart CJR; McCluggage WG; Foulkes WD; Clarke BA; Rouzbahman M
Cancer Treat Res Commun; 2021; 27():100363. PubMed ID: 33838572
[TBL] [Abstract][Full Text] [Related]
25. The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Ann Surg Oncol; 2011 Nov; 18(12):3453-61. PubMed ID: 21541824
[TBL] [Abstract][Full Text] [Related]
26. Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups.
Bartosch C; Exposito MI; Lopes JM
Int J Surg Pathol; 2010 Aug; 18(4):286-91. PubMed ID: 19482859
[TBL] [Abstract][Full Text] [Related]
27. Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations.
Liegl B; Gülly C; Reich O; Nogales FF; Beham A; Regauer S
Histopathology; 2007 Mar; 50(4):448-52. PubMed ID: 17448020
[TBL] [Abstract][Full Text] [Related]
28. Cytologic diagnosis of low grade endometrial stromal sarcoma by staining for estrogen and progesterone receptors.
Reich O; Pickel H; Regauer S
Acta Cytol; 2002; 46(4):790-2. PubMed ID: 12146057
[No Abstract] [Full Text] [Related]
29. Tyrosine kinase receptor status in endometrial stromal sarcoma: an immunohistochemical and genetic-molecular analysis.
Cossu-Rocca P; Contini M; Uras MG; Muroni MR; Pili F; Carru C; Bosincu L; Massarelli G; Nogales FF; De Miglio MR
Int J Gynecol Pathol; 2012 Nov; 31(6):570-9. PubMed ID: 23018215
[TBL] [Abstract][Full Text] [Related]
30. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors.
Tauziéde-Espariat A; Bresson D; Polivka M; Bouazza S; Labrousse F; Aronica E; Pretet JL; Projetti F; Herman P; Salle H; Monnien F; Valmary-Degano S; Laquerrière A; Pocard M; Chaigneau L; Isambert N; Aubriot-Lorton MH; Feuvret L; George B; Froelich S; Adle-Biassette H
J Neuropathol Exp Neurol; 2016 Feb; 75(2):111-20. PubMed ID: 26733585
[TBL] [Abstract][Full Text] [Related]
32. Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma.
Feng W; Hua K; Gudlaugsson E; Yu Y; Zhou X; Baak JP
Histopathology; 2013 Apr; 62(5):675-87. PubMed ID: 23425310
[TBL] [Abstract][Full Text] [Related]
33. Endometrial stromal sarcoma of the uterus: analysis of 25 patients.
Haberal A; Kayikçioğlu F; Boran N; Calişkan E; Ozgül N; Köse MF
Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):209-13. PubMed ID: 12860344
[TBL] [Abstract][Full Text] [Related]
34. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
Feng W; Hua K; Malpica A; Zhou X; Baak JP
Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
[TBL] [Abstract][Full Text] [Related]
35. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study.
Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S
Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015
[TBL] [Abstract][Full Text] [Related]
36. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a multicenter review of 114 cases.
Yoon A; Park JY; Park JY; Lee YY; Kim TJ; Choi CH; Bae DS; Kim BG; Lee JW; Nam JH
Gynecol Oncol; 2014 Jan; 132(1):70-5. PubMed ID: 24184602
[TBL] [Abstract][Full Text] [Related]
38. Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy.
Cheng X; Yang G; Schmeler KM; Coleman RL; Tu X; Liu J; Kavanagh JJ
Gynecol Oncol; 2011 May; 121(2):323-7. PubMed ID: 21277011
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy.
García VM; Batlle JF; Casado E; Burgos E; de Castro J; Belda C; Barriuso J; Sánchez JJ; García-Cabezas MÁ; González-Barón M; Cejas P
Colorectal Dis; 2011 Sep; 13(9):989-98. PubMed ID: 20718834
[TBL] [Abstract][Full Text] [Related]
40. Endometrial stromal sarcoma resembling adenomyosis and menstrual-phase endometrium.
Brunisholz Y; Miller J; Scurry J; Proietto A
Gynecol Oncol; 2004 Oct; 95(1):256-9. PubMed ID: 15385142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
